ATE506949T1 - Kombination aus andolast/glucocorticoiden - Google Patents

Kombination aus andolast/glucocorticoiden

Info

Publication number
ATE506949T1
ATE506949T1 AT06778075T AT06778075T ATE506949T1 AT E506949 T1 ATE506949 T1 AT E506949T1 AT 06778075 T AT06778075 T AT 06778075T AT 06778075 T AT06778075 T AT 06778075T AT E506949 T1 ATE506949 T1 AT E506949T1
Authority
AT
Austria
Prior art keywords
glucocorticoids
andolast
combination
andoalst
calcium
Prior art date
Application number
AT06778075T
Other languages
English (en)
Inventor
Francesco Makovec
Amato Massimo Maria D
Antonio Giordani
Lucio Claudio Rovati
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Application granted granted Critical
Publication of ATE506949T1 publication Critical patent/ATE506949T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
AT06778075T 2006-07-31 2006-07-31 Kombination aus andolast/glucocorticoiden ATE506949T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2006/064840 WO2008014814A1 (en) 2006-07-31 2006-07-31 Combination andolast/glucocorticoids

Publications (1)

Publication Number Publication Date
ATE506949T1 true ATE506949T1 (de) 2011-05-15

Family

ID=37875750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06778075T ATE506949T1 (de) 2006-07-31 2006-07-31 Kombination aus andolast/glucocorticoiden

Country Status (9)

Country Link
US (1) US8809306B2 (de)
EP (1) EP2054057B1 (de)
JP (1) JP5220741B2 (de)
AT (1) ATE506949T1 (de)
CA (1) CA2659435A1 (de)
DE (1) DE602006021638D1 (de)
ES (1) ES2365533T3 (de)
PT (1) PT2054057E (de)
WO (1) WO2008014814A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013056925A (ja) * 2012-11-21 2013-03-28 Rottapharm Spa アンドラスト/グルココルチコイドの併用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1232252B (it) * 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
KR0178893B1 (ko) * 1995-10-04 1999-05-15 김광호 노트북 컴퓨터의 액정 화면부 결합 힌지장치
ATE241980T1 (de) * 1997-08-08 2003-06-15 Rotta Research Lab Neue inhalationspräparate enthaltend cr 2039 (andolast)
GB0009613D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
WO2005123071A1 (en) * 2004-06-14 2005-12-29 Sepracor Inc. Methods of using albuterol and calcium activated potassium channel openers
US20080293788A1 (en) * 2004-06-14 2008-11-27 Sullivan Anne M Methods and Compositions for the Treatment of Pulmonary Diseases
ES2311771T3 (es) 2004-08-19 2009-02-16 Rottapharm S.P.A. Derivados en n-fenilbenzamida como farmacos para el tratamiento de la enfermedad pulmonar obstructiva cronica (epoc).

Also Published As

Publication number Publication date
DE602006021638D1 (en) 2011-06-09
JP5220741B2 (ja) 2013-06-26
CA2659435A1 (en) 2008-02-07
PT2054057E (pt) 2011-05-05
JP2009545537A (ja) 2009-12-24
US20090253664A1 (en) 2009-10-08
WO2008014814A1 (en) 2008-02-07
US8809306B2 (en) 2014-08-19
EP2054057A1 (de) 2009-05-06
ES2365533T3 (es) 2011-10-06
EP2054057B1 (de) 2011-04-27

Similar Documents

Publication Publication Date Title
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
MX2010006823A (es) Metodos para el tratamiento de la gota.
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
TW200716646A (en) (S)-N-methylnaltrexone
MX2010005931A (es) Profarmacos de tetrahidrocanabinol, composiciones que comprenden profarmacos de tetrahidrocanabinol y metodos para utilizar los mismos.
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
MY164646A (en) Nicotine lozenge compositions
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
MX2009007337A (es) Indazoles sustituidos con 5-piridinona.
MX2010001236A (es) Derivados de 5-fenil-isoxazol-3-carboxamida como moduladores del receptor de potencial transitorio v1 (trpv1).
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
UA103930C2 (ru) Соединения и композиция для лечения паразитарных болезней
MX2009007389A (es) Composiciones paras el cuidado oral que comprende extracto de hippophae.
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
IL193252A0 (en) N-hydroxyacrylamide compounds
ATE506340T1 (de) 12-aryl-prostaglandin-analoga
WO2010062506A3 (en) Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
ATE506949T1 (de) Kombination aus andolast/glucocorticoiden
HN2007000505A (es) Analogos de pirazol
WO2009043577A3 (de) 19-nor-progesterone zur kontrazeption
TN2009000448A1 (en) Use of hdac inhibitors for the treatment of bone destruction
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
WO2007116297A3 (en) Use of aminapthone for the preparation of a medicament for treating arteriophaties

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2054057

Country of ref document: EP